Life sciences stocks fall on NIH funding concerns
Source: SeekingAlpha
2025-01-23 12:55:36 ET
More on Illumina, Pacific Biosciences of California, etc.
- Illumina, Inc. (ILMN) 43rd Annual JPMorgan Healthcare Conference - (Transcript)
- 10x Genomics: Struggling Amid Operational Challenges
- Illumina And Grail In 2025? Grounds For Optimism, If Mistakes Aren't Repeated
- Illumina reports preliminary Q4 results, provides 2025 expectations
- PacBio announces preliminary Q4 revenue of $39.2M
Read the full article on Seeking Alpha
For further details see:
Life sciences stocks fall on NIH funding concerns
Revvity Inc.
NASDAQ: RVTY
RVTY Trading
-1.03% G/L:
$84.78 Last:
359,153 Volume:
$85.69 Open:
RVTY Latest News
February 05, 2026 08:00:00 am
Revvity Unveils New High-Impact Discovery Platforms and Showcases Recent Innovations at SLAS2026
RVTY Stock Data
$11,876,096,300
112,241,865
0.04%
224
N/A
Biotechnology & Life Sciences
Healthcare
US
Waltham
